Literature DB >> 11402576

Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction.

A Melman1, G J Christ.   

Abstract

Initiation, maintenance, and modulation of corporal smooth muscle tone are critically dependent upon agonist-induced changes in intracellular calcium levels and mobilization as well as transmembrane calcium flux. The transient control of myocyte excitability and contractility at the cellular level is inextricably linked to membrane potential, which, in turn, is modulated by potassium ion efflux through one of the four known corporeal smooth muscle potassium ion channels. Corporal tissue responses are subsequently coordinated by means of the movement of intracellular second messenger molecules (i.e., IP3, cAMP, cGMP) and ions (i.e., K+ and Ca2+) among the corporal myocytes by means of intercellular communication through gap junction channels. Knowledge of the critical contribution of these interlinking cellular (nonjunctional ion channels [e.g., maxi-K]) and tissue (gap junction channels [e.g., connexin 43]) systems to the modulation of erectile capacity has provided the scientific rationale for the promulgation of the successful preclinical testing of hSlo ion channel gene therapy for the normalization of erectile status in both aged and diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402576     DOI: 10.1016/s0094-0143(05)70133-6

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  10 in total

1.  Color Doppler imaging of erectile dysfunction: a new place in strategy?

Authors:  N Grenier
Journal:  Eur Radiol       Date:  2002-09       Impact factor: 5.315

2.  Effect of icarisid II on diabetic rats with erectile dysfunction and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO-cGMP pathway.

Authors:  Jian Zhang; Ai-Min Li; Bao-Xing Liu; Fei Han; Feng Liu; Shao-Peng Sun; Xin Li; Shu-Jin Cui; Shao-Zhong Xian; Guang-Qi Kong; Zhong-Cheng Xin; Zhi-Li Ji
Journal:  Asian J Androl       Date:  2012-06-25       Impact factor: 3.285

Review 3.  Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.

Authors:  Eric Chung; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

4.  Future strategies for treating erectile dysfunction.

Authors:  Jacob Rajfer; Thomas Magee; Nestor Gonzalez-Cadavid
Journal:  Rev Urol       Date:  2002

5.  Neuroregenerative strategies after radical prostatectomy.

Authors:  Robert C Dean; Tom F Lue
Journal:  Rev Urol       Date:  2005

Review 6.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

7.  Diabetes-induced changes in the alternative splicing of the slo gene in corporal tissue.

Authors:  Kelvin P Davies; Weixin Zhao; Moses Tar; Johanna C Figueroa; Pratik Desai; Vytas K Verselis; Jack Kronengold; Hong-Zhan Wang; Arnold Melman; George J Christ
Journal:  Eur Urol       Date:  2006-11-20       Impact factor: 20.096

Review 8.  Causes of erectile dysfunction.

Authors:  Jeremy P W Heaton; Michael A Adams
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

9.  Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction.

Authors:  Matthias E Werner; Andrea L Meredith; Richard W Aldrich; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

10.  Inhibition of histone deacetylase (HDAC) by 4-phenylbutyrate results in increased junctional conductance between rat corpora smooth muscle cells.

Authors:  Hong Zhan Wang; Barbara Rosati; Chris Gordon; Virginijus Valiunas; David McKinnon; Ira S Cohen; Peter R Brink
Journal:  Front Pharmacol       Date:  2015-02-03       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.